多媒体教育干预未能改善晚期癌症患者对姑息化疗治愈可能性的理解:一项随机临床试验
该多中心随机临床试验纳入186例开始一线或二线姑息化疗的晚期结直肠癌或胰腺癌患者,评估方案特异性视频与手册能否改善其对化疗获益与风险的理解。结果显示,干预组与对照组在3个月时对化疗治愈可能性的准确预期无差异,干预未增加痛苦,其他次要结局相似。
要点
- 视频与手册干预未改变患者对姑息化疗治愈可能性的预期。
- 干预组对不良反应的准确理解在数值上更高但未达统计学显著性。
- 提供坦率的预后信息未增加患者心理痛苦。
核心结论
- 提供教育视频和手册未能改变晚期结直肠癌或胰腺癌患者对姑息化疗治愈可能性的预期。
- 未来可探索替代实施策略,如与护士宣教相结合。
研究设计与样本
- 多中心随机临床试验,在美国5家癌症中心纳入186例开始一线或二线姑息化疗的晚期结直肠癌或胰腺癌患者,入组时间2015年6月至2017年9月,随访至2019年12月。
- 94例随机分配至常规护理组,92例分配至干预组;平均年龄59.3岁(SD 12.6,范围28-86),男性107例(58%),结直肠癌118例(63.4%),胰腺癌68例(36.6%)。
- 干预为方案特异性姑息化疗视频和手册,内容涵盖治疗安排、潜在获益、预期寿命(可选)、不良反应及替代方案,视频由真实患者分享多样体验。
主要发现
- 主要结局(3个月时对化疗治愈可能性的准确预期,即回答「完全不可能」)在干预组为52.6%(95%CI 40.3%-65.0%),对照组为55.5%(95%CI 45.1%-66.0%),两组无差异。
- 干预未增加痛苦,尽管提供了坦率的预后信息;其他次要结局两组相似。
关键数值与推荐
- 主要结局定义为3个月时对「您认为化疗治愈您癌症的可能性有多大?」回答「完全不可能」。
- 多数患者希望获得「大量」或「尽可能多」关于不良反应(149例,80.1%)、治愈可能性(148例,79.6%)和预后(148例,79.6%)的信息。
- 干预组中59例(78%)在2周内阅读了手册,30例(40%)观看了视频。
临床怎么用
- 单纯提供方案特异性视频和手册不足以纠正晚期癌症患者对姑息化疗治愈可能性的不准确预期。
- 可考虑将教育材料与护士宣教等替代实施策略整合,以期改善患者理解。
局限性
- 干预组中仅40%的患者在2周内观看了视频,实际干预暴露程度有限。
- 准确不良反应理解的组间差异未达到统计学显著性阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite requirements of informed consent, patients with advanced cancer often receive palliative chemotherapy (PC) without understanding that the likelihood of cure is remote. OBJECTIVE: To determine whether a PC educational video and booklet at treatment initiation could improve patients' understanding of its benefits and risks. INTERVENTIONS: Regimen-specific PC videos and booklets presenting information about logistics, potential benefits, life expectancy (optional), adverse effects, and alternatives. Videos featured authentic patients sharing diverse experiences. After receiving treatment recommendations, research assistants distributed materials to patients for independent review. DESIGN, SETTING, AND PARTICIPANTS: Multicenter randomized clinical trial of patients with advanced colorectal or pancreatic cancer starting first-line or second-line PC in 5 US cancer centers with enrollment from June 2015 to September 2017 and follow-up to December 2019. MAIN OUTCOMES AND MEASURES: The primary outcome was accurate expectations of chemotherapy benefits at 3 months, defined as responding "not at all likely" to "What is your understanding of how likely the chemotherapy is to cure your cancer?" (from the Cancer Care Outcomes Research and Surveillance study). Secondary outcomes included understanding of adverse effects, decisional conflict (SURE test), regret (Decisional Regret Scale), and distress (Functional Assessment of Cancer Therapy-General emotional well-being subscale). RESULTS: Among 186 patients with advanced colorectal or pancreatic cancer who were starting first-line or second-line PC (94 randomized to usual care, 92 to intervention; mean [SD] age, 59.3 [12.6] [range, 28-86] years; 107 [58%] male; 118 [63.4%] colorectal and 68 [36.6%] pancreatic cancer), most patients wanted "a lot" of information or "as much information as possible" about adverse effects (149, 80.1%), likelihood of cure (148, 79.6%), and prognosis (148, 79.6%). Among the intervention arm, 59 (78%) reviewed the booklet and 30 (40%) reviewed the video within 2 weeks. The primary outcome did not differ between intervention and control arms (52.6%; 95% CI, 40.3%-65.0%; vs 55.5%; 95% CI, 45.1%-66.0%). Accurate adverse effect understanding was more common among intervention than control patients (56.0%; 95% CI, 44.3%-67.7%; vs 40.2%; 95% CI, 29.5%-50.9%; P = .05), although this did not meet the threshold for statistical significance. The intervention did not increase distress, despite frank prognostic information. Other secondary outcomes were similar. CONCLUSIONS AND RELEVANCE: Provision of an educational video and booklet did not alter patients' expectation of cure from PC. Alternative delivery strategies, such as integration with nurse teaching, could be explored in future studies. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02282722.
引用
- Enzinger AC, Uno H, McCleary N, et al. Effectiveness of a Multimedia Educational Intervention to Improve Understanding of the Risks and Benefits of Palliative Chemotherapy in Patients With Advanced Cancer: A Randomized Clinical Trial. JAMA Oncol. 2020. PMID: 32672806. doi:10.1001/jamaoncol.2020.1921
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。